Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Immucor CEO De Chirico

This article was originally published in The Gray Sheet

Executive Summary

Chairman Edward Gallup will take over CEO duties "on an interim basis" from Gioacchino De Chirico while the firm conducts an internal investigation related to "alleged improper cash payments" by Immucor and other firms, made "in exchange for favorable contract awards" by an Italian hospital, the firm says. De Chirico will retain his other title of president during the investigation, which parallels a criminal investigation by Italian authorities. The hospital administrator apparently had received an improperly documented payment of about $17,000 to organize an Immucor-sponsored convention, according to the company...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT021141

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel